Literature DB >> 19828288

Diagnosis of inferior sinus venosus atrial septal defects using transthoracic three-dimensional echocardiography.

Chun-An Chen1, Jou-Kou Wang, Jui-Yu Hsu, Hsao-Hsun Hsu, Shyh-Jye Chen, Mei-Hwan Wu.   

Abstract

The authors report the cases of 2 patients with symptoms and signs related to severe pulmonary hypertension. Two-dimensional echocardiography demonstrated defects in the posterior portion of the atrial septum. Transthoracic three-dimensional echocardiography clearly showed inferior sinus venosus atrial septal defects and their relationships with the inferior vena cava, the pulmonary vein, and the muscular border of the fossa ovalis. These 2 cases not only elucidate the potential value of transthoracic three-dimensional echocardiography in delineating the structural characteristics of unusual interatrial shunting but also remind clinicians to be aware of this potentially treatable cardiac defect during workup for pulmonary hypertension. Copyright 2009 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19828288     DOI: 10.1016/j.echo.2009.09.008

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  2 in total

1.  MRI for detection of anomalous pulmonary venous drainage in patients with sinus venosus atrial septal defects.

Authors:  Maria Prompona; Olaf Muehling; Michael Naebauer; Stefan O Schoenberg; Maximilian Reiser; Armin Huber
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-05       Impact factor: 2.357

2.  The Parasternal Short-Axis View Improves Diagnostic Accuracy for Inferior Sinus Venosus Type of Atrial Septal Defects by Transthoracic Echocardiography.

Authors:  Brian S Snarr; Michael Y Liu; Jeremy C Zuckerberg; Christine B Falkensammer; Sumekala Nadaraj; Danielle Burstein; Deborah Ho; Monique A Gardner; Arene Butto; Stanford G Ewing; Natesa G Pandian; Anirban Banerjee
Journal:  J Am Soc Echocardiogr       Date:  2017-01-27       Impact factor: 5.251

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.